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7RESEARCH ARTICLE Open AccessEvaluation of liver parenchyma and perfusion
using dynamic contrast-enhanced computed
tomography and contrast-enhanced
ultrasonography in captive green iguanas
(Iguana iguana) under general anesthesia
Giordano Nardini1*, Nicola Di Girolamo2, Stefania Leopardi1, Irene Paganelli1, Anna Zaghini3,
Francesco C Origgi4 and Massimo Vignoli5Abstract
Background: Contrast-enhanced diagnostic imaging techniques are considered useful in veterinary and human
medicine to evaluate liver perfusion and focal hepatic lesions. Although hepatic diseases are a common occurrence
in reptile medicine, there is no reference to the use of contrast-enhanced ultrasound (CEUS) and contrast-enhanced
computed tomography (CECT) to evaluate the liver in lizards. Therefore, the aim of this study was to evaluate the
pattern of change in echogenicity and attenuation of the liver in green iguanas (Iguana iguana) after administration
of specific contrast media.
Results: An increase in liver echogenicity and density was evident during CEUS and CECT, respectively. In CEUS, the
mean ± SD (median; range) peak enhancement was 19.9% ± 7.5 (18.3; 11.7-34.6). Time to peak enhancement was
134.0 ± 125.1 (68.4; 59.6-364.5) seconds. During CECT, first visualization of the contrast medium was at 3.6 ± 0.5
(4; 3-4) seconds in the aorta, 10.7 ± 2.2 (10.5; 7-14) seconds in the hepatic arteries, and 15 ± 4.5 (14.5; 10-24) seconds
in the liver parenchyma. Time to peak was 14.1 ± 3.4 (13; 11-21) and 31 ± 9.6 (29; 23-45) seconds in the aorta and
the liver parenchyma, respectively.
Conclusion: CEUS and dynamic CECT are practical means to determine liver hemodynamics in green iguanas.
Distribution of contrast medium in iguana differed from mammals. Specific reference ranges of hepatic perfusion
for diagnostic evaluation of the liver in iguanas are necessary since the use of mammalian references may lead the
clinician to formulate incorrect diagnostic suspicions.Background
Although in reptiles hepatic diseases are traditionally
suspected to be secondary to husbandry mismanage-
ment, hepatic diseases caused by parasitic infestations
[1], viral [2-4] and bacterial [5,6] infections, and neo-
plastic proliferations [7,8] are sporadically reported in
the literature.
Even though hepatic diseases are quite common in
reptiles they are hardly diagnosed ante mortem due to* Correspondence: giordano.nardini@gmail.com
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unless otherwise stated.the ambiguous clinical signs [2,4,5]. Furthermore, the
function of the reptilian liver is markedly influenced by
age, sex, physiological condition, temperature, and other
environmental conditions [9]. Changes in the organ’s
size, color, and texture, as well as alterations of biochem-
ical parameters [10] may therefore be alternatively consid-
ered either normal or related to hepatic diseases. For
example, in chelonians there are physiological fluctuations
of liver enzymes that depend on the seasons and on the
gender [11,12]. Therefore, the diagnosis of liver patho-
logical conditions is challenging and evaluation of the liver
through multiple approaches is often necessary.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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scopic technique for collection of liver biopsy specimens
has been described [13]. Endoscopic biopsy is a powerful
technique, especially when dealing with multifocal/
diffuse diseases. Unfortunately, there are no data in the
current literature describing the sensitivity of liver endo-
scopic biopsy when dealing with focal hepatic disease.
Although to achieve a definitive diagnosis tissue biopsy
may be required, a preliminary characterization of liver
parenchyma and perfusion by use of non-invasive im-
aging techniques may be useful to evaluate the presence
of lesions, to localize them and to determine the extent
of their distribution.
In companion animal medicine, several techniques allow
morphological evaluations of the liver. Among them,
ultrasonography has been widely employed, while com-
puted tomography (CT) and contrast-enhanced computed
tomography (CECT) are being increasingly utilized [14].
Although ultrasonography provides details on the mor-
phology and the vascularization of the liver, contrast-
enhanced ultrasound (CEUS), based on the injection of
specific contrast agents, allows the investigation of the
perfusion of tissues [15]. When a tissue is perfused with
an ultrasound contrast agent, analysis of grayscale images
collected over an appropriate duration of time permits
creation of time–intensity curves for a chosen region of
interest. Mathematical analysis of these time–intensity
curves yields quantitative hemodynamic indices relating to
blood flow in either tissue volumes or within individual
vessels [15]. Perfusion parameters are of interest since
changes in vascularity and blood flow secondary to path-
ology generate alterations in the time–intensity curve [16].
Furthermore, contrast-enhanced ultrasound allows a more
complete characterization of focal lesions [17].
In canine patients contrast-enhanced ultrasonography
appears to improve the characterization of focal and
multifocal hepatic lesions [18] and in humans CEUS de-
tected significantly more focal liver lesions than unen-
hanced ultrasonography [19]. Apart for imaging of the
liver [17,18] CEUS has also been demonstrated to be a
useful for imaging other organs including canine spleen
[17,20], lymph nodes [21], prostate [22,23] kidneys
[24,25], and adrenals [26].
Computed tomography may also provide useful clin-
ical information when used to evaluate perfusion of
hepatic parenchyma and of focal hepatic lesions [27,28].
Although in reptiles CT has been historically used to
describe the normal anatomy [29-33], more recently,
probably due to the easier access to CT scanners, it
has been employed for clinical evaluation of anatomical
changes [34,35]. Therefore, description of reference
ranges for liver hemodynamics of healthy individuals
may be useful to permit assessment of the liver in
clinical settings.Although both CECT and CEUS could be powerful
diagnostic tools to evaluate liver morphology and perfu-
sion, to the best of the authors’ knowledge, no studies
have so far evaluated their use in reptiles. Therefore, the
aim of this study was to evaluate architecture and perfu-
sion of the liver in green iguanas (Iguana iguana) by use
of CECT and CEUS, to serve as a reference for future
clinical studies. The specific hypothesis was that distri-
bution of the contrast media after intravenous injection
in a peripheral vein would result in a rise in echogenicity
and attenuation of the liver, and therefore CECT and
CEUS would be useful tools to evaluate liver perfusion.Results
Population summary
Of eleven iguanas presented in the study period, eight
(7 males, 1 female) met the criteria for inclusion in the
study. Two iguanas were excluded for clinical abnor-
malities, and one iguana was excluded due to abnormal
values on serum biochemistry. Mean age of the included
iguana was 9 years (range 2-18 yr), and mean body weight
was 1.9 kg (range 1.1-2.8 kg). All the iguanas recovered
uneventfully from anesthesia and no notable complica-
tions were associated with the procedure. Histological
examination did not reveal the presence of significant
tissue changes except for a mild to moderate degree of
hepatic lipidosis detected in all the liver samples observed.CEUS
Upon B-mode ultrasonography, the liver was easily vi-
sualized in all iguanas (Figure 1A). After the injection of
contrast medium (wash in phase, Figure 1B) an increas-
ing echogenicity in the hepatic arteries was initially ob-
served, followed by a more diffuse and homogenous
enhancement of the liver parenchyma during the portal
phase, until the peak intensity was reached (Figure 1C).
During the wash out phase, a homogenous decrease of
the echogenicity was visible in all cases (Figure 1D).
Complete clearance of the contrast medium was not
achieved neither in the 3 individuals in which image ac-
quisition ran for 10 minutes. Representative frames of
the scanning sequence after contrast medium adminis-
tration from one of the iguanas are shown in Figure 1,
and a representative time–intensity curve over the re-
gion of interest is shown in Figure 2.
The mean peak enhancement was 19.9% ± 7.5 (18.3;
11.7-34.6). TTPceus was 134.0 ± 125.1 (68.4; 59.6-364.5)
seconds. Distribution of both peak enhancement and
TTPceus were normal and no outliers were detected.
Repeatability of CEUS was adequate, with intra-
individual variations of peak enhancement and TTPceus
of 10.5% and 1.2%, respectively.
Figure 1 Representative ultrasonographic evaluation of the liver of an iguana included in the study. Artifacts secondary to the scales are
visible during B-mode examination (A). At T0, before injection of contrast media, (B) no contrast enhancement of the liver vessels is present,
while enhancement it is well visible 36 (C) and 90 (D) seconds after contrast medium injection.
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Liver parenchyma and margins were easily visualized in
the plain CT scan (Figure 3). Basal liver attenuation as
measured through CT scan analysis was 77.3 ± 6.2 HU
reaching 179.1 ± 35 HU at peak enhancement. The first
visualization of the contrast medium was at 3.6 ± 0.5 (4;
3-4) seconds in the aorta, 10.7 ± 2.2 (10.5; 7-14) seconds
in the hepatic arteries, and 15 ± 4.5 (14.5; 10-24) seconds
in the liver parenchyma. TTPcect in the aorta was 14.1 ±
3.4 (13; 11-21) seconds. TTPcect in the liver parenchyma
was 31 ± 9.6 (29; 23-45) seconds. One iguana (No. 8) was
found to be an outlier, presenting slower enhancement in
aorta (21 seconds) and slower arrival of contrast mediumFigure 2 Time-intensity curve of the distribution of SonoVue in the liin the liver (24 seconds) than the population studied
(Figure 4) and was excluded from the descriptive statis-
tics. A time-intensity curve representative of the popu-
lation studied is reported in Figure 5.
Discussion
Results of the present study indicate that imaging tech-
niques employing intravenous distribution of contrast
media may be used in green iguanas to evaluate liver
texture and perfusion. The distribution of the contrast
agent within the liver either during contrast-enhanced
ultrasound and contrast-enhanced computed tomography
was accompanied by a clearly recognizable change in liverver of a representative green iguana.
Figure 3 Representative dynamic CT study of an iguana included in the study. No vascular enhancement is present in the vessels just after
the contrast medium injection (A); the contrast medium is present in the caudal vena cava, but not in the aorta 3 seconds after injection (B);
36 seconds after injection is well visible in all the liver parenchyma (C), and after 600 seconds from the injection start, the contrast medium it is
still mildly appreciable (D). Beam hardening (arrowheads - A) and blooming (arrows – B) artifacts are present due to ribs, and the pool of contrast
medium in the caudal vena cava respectively.
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vasive techniques, such as endoscopic biopsy [13], have
been previously employed to evaluate the liver in green
iguanas, but to the authors knowledge, this is the first time
that enhancement of liver tissue in iguanas after admin-
istration of contrast media during CT and ultrasound
examinations is evaluated. Although liver biopsy is con-
sidered to be the gold standard for diagnosing hepatic
diseases, it may be useful to have reference ranges for
diagnostic imaging techniques that permit evaluation of
liver hemodynamics.
By use of the same contrast medium employed in the
present study, during CEUS examination of the liver in
dogs [15,36] a (1) hepatic arterial phase at 10-25 s post-
injection has been defined, followed by a (2) portal vein
phase at 20-90 seconds post-injection. This last phase
lasted 150-240 seconds. Such phases reflect the double
vascularization of the hepatic tissue by the hepatic artery
(20% to 30% of blood) and the portal vein (70% to 80%of blood) [15,37]. In green iguanas we observed a similar
pattern, characterized by a (1) increased echogenicity of
the hepatic arteries and (2) diffuse enhancement of the
liver parenchyma, until the peak intensity was reached.
The wash out phase in the iguanas was characterized by
a gradual decrease in echogenicity of the liver paren-
chyma. In all cases enhancement of the liver lasted for
more than 10 minutes.
There are two findings of the present study that are
worthy of mention, as they strongly differed from what
is expected in mammals. Firstly, time to peak, a measure
of the time needed to the contrast medium to provide
the maximum enhancement of a target organ (ie, the
liver), was determined to be 134 (range 59-364) seconds
in our study, drastically longer than what is described in
dogs and cats. In conscious and anesthetized dogs, time
to peak enhancement occurred among 15 to 46 seconds
after injection of the contrast media [15,36]. In cats,
time to peak occurred approximately 10 seconds after
Figure 4 Box-and-whisker plots of distribution of contrast
medium (CM) in liver of healthy green iguana as evaluated by
means of dynamic CT scan. Appearance of CM in aorta (1), time to
peak in aorta (2), appearance of CM in liver vessels (3), detection of
CM in the liver (4), time to peak in the liver (5). The boxes represent
the values from the first to the third quartile. The horizontal line in
each box represents the median. The whiskers include values of 1.5
times the interquartile range. Dots represent values that are larger
than the upper quartile plus 3 times the interquartile range.
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ment of liver parenchyma from approximately 10 dB of
baseline intensity to approximately 30 dB of peak intensity
[38]. This finding is especially relevant because (1) if re-
sults of CEUS examination of green iguanas are inter-
preted extrapolating current knowledge on dogs and cats,
healthy green iguanas would be suspected to suffer a
delay in reach of time to peak enhancement. Further-
more, (2) when performing contrast-enhanced imaging
techniques to evaluate the liver in lizards, longer studies
should be planned than that performed in mammals.Figure 5 Time-density curves for aorta and liver during 600 secondsThe second unexpected finding was the inter-individual
variance observed in time to peak enhancement. In pre-
vious studies on dogs and cats, time to peak was charac-
terized by a relatively small standard deviation: in 11
dogs the standard deviation was of 20 seconds (mean
34.6 seconds) and in 10 cats the standard deviations was
of 2.9 seconds (mean 9,6 seconds) [36,38]. This suggests
that time to peak is a parameter somehow consistent
among individuals of the same species. In contrast, in
the iguanas studied here TTPceus varied greatly among
individuals with a much higher standard deviation (over
100 seconds). Due to the design of our study it is impos-
sible to objectively determine which factor was responsible
for such high inter-individual variability. We suppose
that the greater variance for time to peak observed in
this study may be secondary to intrinsic factors (eg,
vitellogenesis, large variation in the age of the iguanas),
or to the use of chemical restraint. In fact, although all
the iguanas underwent the same anesthetic protocol, ef-
fect of anesthetic agents has historically been consid-
ered to show much greater variability among reptiles
that in mammals [39].
In the present study all the examinations have been per-
formed in iguanas under general anesthesia. Although in
aggressive iguanas chemical restraint may be necessary to
perform CEUS safely, in most occasions manual restraint
should be sufficient to perform a standard CEUS examin-
ation of the liver in clinical setting. To facilitate the exam-
ination the stimulation of the vaso-vagal response, via
light digital pressure applied to the eyelids, could be per-
formed [40]. Nevertheless, it should be taken in account
that results obtained in the present study may not apply to
conscious iguanas or iguanas in which the baroreceptor
reflex has been stimulated: In a previous study evaluating
CEUS of the liver in dogs, time to peak enhancement wasof investigation in a representative iguana.
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propofol [36]. Such difference was suspected to be second-
ary to the effect that propofol has on the vascular system
(ie, increase in hepatic arterial blood flow and decrease of
systemic arterial pressure [41]). In any case, the other pa-
rameters did not differ in conscious and anesthetized indi-
viduals. Therefore, when considering the values produced
in our study, the use of anesthetic drugs has to be consid-
ered, especially concerning time to peak enhancement.
Unenhanced CT scans provided excellent visualization
of lizard’s liver. Contrast-enhanced computed tomography
permitted further investigation of perfusion. Time-density
curves obtained in iguanas were not dissimilar to curves
that are usually obtained in mammals [42]. The graphic
obtained for the aorta was characterized by a very pendant
curve during wash-in with a high peak, and an initial rapid
decrease followed by a slower second phase during wash-
out. In the liver the wash-in phase was slower and the
peak lower, whereas the pattern after peak was similar to
that of the aorta, both of which did not complete washout
during the 600 seconds of investigation. The curve pattern
appeared quite similar in all animals studied apart from
a few differences noted in the graphs for iguana No. 8.
The distribution of the contrast medium in Iguana No. 8
was characterized by slower TTPcect in aorta and slower
visualization of contrast medium in the liver, resulting in
an evident right shifting of the time-density curve. In all
the individuals studied the contrast medium was still par-
tially visible in the aorta and in the liver after a 600 seconds
period of investigation. Such slower wash out phase com-
pared to mammals [36] is probably caused by the lower
metabolic rates of reptiles, which averages 25% to 35% of
that of mammals [43].
Minimal fluctuations visualized in some of the time-
intensity curves were probably associated with the respira-
tory acts of the iguanas. Although difficulties on keeping
the ROI in the middle of the scanned area of the liver is
reported also in anesthetized cats [38], we suspect that in
reptiles, the fluctuations secondary to the relation between
lung size and pressure in visceral organs may be more
relevant due the absence of a muscular diaphragm.
In the present study absolute values for mean gray
level were reported only when strictly necessary, as these
values may be affected by several variables such as gain
setting, mechanical index, scanning depth, the size and
body composition of the individual animal, and the be-
havior of the individual contrast medium [36]. Changes
in attenuation of the liver are for example described in
chelonians, in which hypoattenuating liver (ie, < 20
Hounsfield Units) was associated with hepatic lipidosis
[44]. Considering that a moderate grade of liver steatosis
was present in the individuals studied, it is possible to
hypothesize that iguanas without any degree of steatosis
may present a more attenuating liver parenchyma.Another factor that should be taken in account, when-
ever the present study is used as a reference, is that the
contrast medium was injected into the ventral tail vein.
The other reasonable vascular accesses in iguanas are
the cephalic vein and the jugular vein, although they
usually require a surgical incision of the skin [45]. Some
differences in time to peak enhancement may be expected
if injection of the contrast medium is performed in a dif-
ferent vein due to the different endovascular transit done
by the contrast medium.
Proper cohort or case-control studies in iguanas would
be ideal to identify an increased risk in mortality or in
adverse events in animals undergoing CEUS or CECT
[46]. Such typology of studies is rarely performed in reptile
medicine due to the overall limited number of reptile pa-
tients, and to the multitude of confounding factors that
should be considered (eg, species, metabolism, housing).
Nevertheless, based on the lack of complications in the
present study and based on evidence recently acquired in
dogs and cats [47], there is no indication to suppose that
these techniques are harmful.
Conclusions
Normal liver attenuation and perfusion were determined
by evaluation of the contrast medium diffusion in the
parenchyma. Time-density curves of the liver were charac-
terized by a fast time to peak and a slow wash out which
was not completed during the recorded time. An import-
ant inter-individual variation is present in clinically healthy
iguanas. However, due to the small population sampled
in this study we cannot determine whether this is a con-
sistent phenomenon in this species.
Further studies in iguanas with hepatic diseases are
needed in order to evaluate potential differences in the
attenuation between normal and abnormal livers. In par-
ticular, inclusion of lizards with focal hepatic lesions would
be aimed, as characterization of focal lesions is one of the
most powerful applications of contrast-enhanced imaging
techniques. Lastly, future studies including captive and
wild iguanas may allow evaluation of whether the moder-
ate lipidosis observed in the hepatic samples was second-
ary to housing or dietary conditions.
Methods
Animals
Clinically healthy, client-owned, captive-born green iguanas
(Iguana iguana) presented to the Clinica Veterinaria
Modena Sud (Spilamberto, MO, Italy) in a three-month
period were eligible for inclusion in the study. To be in-
cluded in the study iguanas needed to have no previous
pathologies reported and to be maintained in proper
dietary (ie, fed mixtures of leafy green vegetables and
had access to water ad libitum) and housing conditions
(ie, presence of a basking spot reaching 35°C [95°F],
Nardini et al. BMC Veterinary Research 2014, 10:112 Page 7 of 9
http://www.biomedcentral.com/1746-6148/10/112UVB lamps replaced at least biannually, exposure to
natural sunlight in spring and summer). The animals
were considered healthy on the basis of physical examin-
ation and of clinical biochemistry values within published
reference ranges [48,49]. Biochemistry was performed by
means of a bench-top analyzer (VetScan, Abaxis, Inc.,
Union City, CA) that use commercially available rotor de-
signed to be used in Avian/Reptilian patients. Parameters
analysed for each animal were albumin, aspartate trans-
aminase, biliary acid, calcium, creatine kinase, glucose,
phosphorus, potassium, sodium, total protein, and uric
acid.
The study was performed in compliance with the dir-
ective 2010/63/EU of the European parliament and of
the European council. The institutional ethical committee
of the University of Bologna approved all the procedures.
The owners gave written informed consent for the enrol-
ment of their animals in the study.
Procedures
The ventral tail vein of each iguana was catheterized
using a 22 gauge IV catheter (Jelco, Smiths Medical
International Ltd, Lancashire, UK) inserted at two-thirds
of the tail length. Anesthesia was induced with a slow
intravenous 10 mg/kg [4.54 mg/lb] injection of propofol
(Fresenius Kabi, Isola della Scala, Italy) [50] with the
animals maintained in a warm room (28°C [82.4°F]) for
24 hours before the procedure. Iguanas were intubated
with non-cuffed tracheal tube (with diameter between
2.0 and 3.0 mm) and connected to a closed Y pediatric
circuit. Anesthesia was maintained administering 2.0%
isoflurane and 0.8-1.2 litre/minute oxygen through an
adjustable dial (concentration range, 0-5%) coupled with
a separate oxygen flow meter (range, 0.2-4 L/min).
Manual ventilation was performed if apnea lasted more
than 20 seconds. The heart rate was monitored through
a doppler probe placed on the jugular vein during the
entire procedure. Ultrasound and CT scans were per-
formed as described below. Following the imaging session
ultrasound-guided liver biopsies were obtained from each
iguana. After the procedures the iguanas were individually
placed in a small warm enclosure (32°C [89.6°F]) and
closely monitored during recovery from anesthesia.
Ultrasonography procedures
A survey liver scan was performed using standard B-mode
ultrasonography with 5-7.5 MHz linear transducer with
coded harmonic capability (Esaote Mylab 30, Esaote-CnTI
System, Esaote, Genova, Italy), to ensure there were no
visible liver lesions, and to permit selection of a suitable
acoustic window, i.e., one that provided an uninterrupted
view of as large a section of liver parenchyma as possible.
The animals were maintained in ventro-dorsal position,
and large amount of gel was used in order to reduceartifacts caused by entrapment of air bubbles in between
the scales.
A second-generation contrast agent composed of sulphur
hexafluoride microbubbles (SonoVue 8 mcl/ml, Bracco
Imaging S.p.A., Milan, Italy) and a dedicated contrast-
enhanced ultrasound analytical software (Contrast Tuned
Imaging, Contrast Tuned Imaging technology, Esaote,
Genova, Italy) were used. When an appropriate acoustic
window was found, a rapid bolus dose of 0.03 ml/kg of the
contrast medium was injected through the IV catheter
followed by a rapid bolus of 1.5 ml of saline (0.9% NaCl).
The timer was activated at the moment of the injection
(T = 0) and the flow of contrast into the liver was observed
in real-time and digitally recorded for 1 minute and
30 seconds. On the first 5 iguanas two consecutive
CEUS examinations were performed 30 minutes apart
to assess repeatability of the method. As results of the
first 5 examinations showed that in 1.5 minutes there
was no clearance of the contrast medium in the liver,
recording was prolonged to 10 minutes.
Videos were analyzed using specific software (Qontrast,
Esaote, Italy) to generate time-intensity curves for each
exam. The peak enhancement and time to peak (TTPceus)
were calculated for each individual. Perfusion parameters
were defined as follows: peak enhancement (maximum
signal intensity reached during the transit of the bolus,
expressed in % where 100% means the maximum),
TTPceus (time of arrival of contrast agent post-injection
to its maximum peak enhancement value).
CT procedures
Dynamic CT images were obtained by use of a multidetec-
tor 16 slices CT scanner (BrightSpeed 16, GE Corporate,
Milwaukee, WI) with the animals being in ventral recumb-
ence. After the plain images were taken, a section of the
liver close to the hilum was chosen and one image was
taken every second starting from the injection time for a
total of 600 images, in order to obtain curves of liver per-
fusion enhancement. A dose of 800 mg/kg of an iodinated
contrast medium (Ioversol 320 mg/ml, Optiray, Covidien
Spa, Italy) [42], was injected trough the ventral tail vein,
at 3 ml/sec, using a power injector (Optistar injector,
Mallinckrodt plc, Dublin, Ireland).
Liver attenuations in the plain studies and at peak en-
hancement were determined. Time of first visualization
of contrast media in the aorta, in the hepatic arteries,
and in the liver parenchyma was recorded. Times to
peak (TTPcect) in aorta and in the liver parenchyma were
also determined by visual inspection of the curves.
Histopathological procedures
A biopsy device (Spirotome 10 G, Medinvents NV,
Hasselt, Belgium) composed by cutting cannula, trocar,
helical tissue receiving needle, and releasing device with a
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the iguanas, according to the technique previously de-
scribed in companion animals [51]. A small cutaneous in-
cision was performed with a number 11 scalpel blade in
the iguanas to facilitate the introduction of the device
through the skin. The biopsies were taken both from the
right and the left lobe, distant from any visible vessel. A
total of 16 biopsies (two per each animal), were collected
by a board-certified radiologist (MV).
Tissue samples were immediately placed into 2 ml
screw-top plastic tubes containing 10% buffered formalin.
The tissues were then routinely processed and stained
with hematoxylin and eosin. Tissue sections were exam-
ined by a board-certified veterinary pathologist (FCO).Statistical analysis
Statistical analysis was performed by use of a commercial
software (MedCalc 12.2.1, MedCalc Software, Mariakerke,
Belgium). Data are reported as mean ± SD (median; range)
unless otherwise stated. P-values less than 0.05 were
considered significant. Non-normality was investigated
for each parameter through the D’Agostino-Person test.
Tukey method was employed to detect outliers, i.e.,
values smaller than the lower quartile minus 1.5 times
the interquartile range, or larger than the upper quartile
plus 1.5 times the interquartile range. Repeatability of
TTPceus and CEUS peak enhancement was measured
calculating the CV from duplicate measurement [52].Competing interests
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